Search research articles
Contact Us
Filters
Showing results (21-30 of 111) with videos related to
Page
of 12
Sort By:
The Journal of Dermatology
|
March 8, 2023
Efficacy and safety of the selective TYK2 inhibitor, deucravacitinib, in Japanese patients with moderate to severe plaque psoriasis: Subgroup analysis of a randomized, double-blind, placebo-controlled, global phase 3 trial
Shinichi Imafuku, Yayoi Tada, Lauren Hippeli, et al.
Gastroenterology
|
January 10, 2002
Distinct inflammatory mechanisms mediate early versus late colitis in mice
David M Spencer, Geertruida M Veldman, Subhashis Banerjee, et al.
Endocrinology
|
January 7, 2015
ROR inverse agonist suppresses insulitis and prevents hyperglycemia in a mouse model of type 1 diabetes
Laura A Solt, Subhashis Banerjee, Sean Campbell, et al.
Scientific Reports
|
April 22, 2024
Streamlining neuroradiology workflow with AI for improved cerebrovascular structure monitoring
Subhashis Banerjee, Fredrik Nysjö, Dimitrios Toumpanakis, et al.
The Journal of Allergy and Clinical Immunology
|
November 12, 2021
Molecular and clinical effects of selective tyrosine kinase 2 inhibition with deucravacitinib in psoriasis
Ian M Catlett, Yanhua Hu, Lu Gao, et al.
Rheumatology and Therapy
|
July 5, 2025
Efficacy and Safety of Deucravacitinib, a Selective, Allosteric TYK2 Inhibitor, by Baseline DMARD Use in a Phase 2 Psoriatic Arthritis Study: A Post Hoc Analysis
Atul Deodhar, Miroslawa Nowak, June Y Ye, et al.
Plos One
|
May 20, 2016
Correction: Pharmacological and Genetic Modulation of REV-ERB Activity and Expression Affects Orexigenic Gene Expression
Ariadna Amador, Yongjun Wang, Subhashis Banerjee, et al.
Peptides
|
October 25, 2021
Adropin transgenesis improves recognition memory in diet-induced obese LDLR-deficient C57BL/6J mice
Sarbani Ghoshal, Subhashis Banerjee, Jinsong Zhang, et al.
Plos One
|
March 11, 2016
Pharmacological and Genetic Modulation of REV-ERB Activity and Expression Affects Orexigenic Gene Expression
Ariadna Amador, Yongjun Wang, Subhashis Banerjee, et al.
Arthritis Research & Therapy
|
December 8, 2018
Improved patient-reported outcomes in patients with psoriatic arthritis treated with abatacept: results from a phase 3 trial
Vibeke Strand, Evo Alemao, Thomas Lehman, et al.
Page
of 12
Search research articles
Search
Showing results (21-30 of 111) with videos related to
Sort By:
Page
of 12
The Journal of Dermatology
|
March 8, 2023
Efficacy and safety of the selective TYK2 inhibitor, deucravacitinib, in Japanese patients with moderate to severe plaque psoriasis: Subgroup analysis of a randomized, double-blind, placebo-controlled, global phase 3 trial
Shinichi Imafuku, Yayoi Tada, Lauren Hippeli, et al.
Gastroenterology
|
January 10, 2002
Distinct inflammatory mechanisms mediate early versus late colitis in mice
David M Spencer, Geertruida M Veldman, Subhashis Banerjee, et al.
Endocrinology
|
January 7, 2015
ROR inverse agonist suppresses insulitis and prevents hyperglycemia in a mouse model of type 1 diabetes
Laura A Solt, Subhashis Banerjee, Sean Campbell, et al.
Scientific Reports
|
April 22, 2024
Streamlining neuroradiology workflow with AI for improved cerebrovascular structure monitoring
Subhashis Banerjee, Fredrik Nysjö, Dimitrios Toumpanakis, et al.
The Journal of Allergy and Clinical Immunology
|
November 12, 2021
Molecular and clinical effects of selective tyrosine kinase 2 inhibition with deucravacitinib in psoriasis
Ian M Catlett, Yanhua Hu, Lu Gao, et al.
Rheumatology and Therapy
|
July 5, 2025
Efficacy and Safety of Deucravacitinib, a Selective, Allosteric TYK2 Inhibitor, by Baseline DMARD Use in a Phase 2 Psoriatic Arthritis Study: A Post Hoc Analysis
Atul Deodhar, Miroslawa Nowak, June Y Ye, et al.
Plos One
|
May 20, 2016
Correction: Pharmacological and Genetic Modulation of REV-ERB Activity and Expression Affects Orexigenic Gene Expression
Ariadna Amador, Yongjun Wang, Subhashis Banerjee, et al.
Peptides
|
October 25, 2021
Adropin transgenesis improves recognition memory in diet-induced obese LDLR-deficient C57BL/6J mice
Sarbani Ghoshal, Subhashis Banerjee, Jinsong Zhang, et al.
Plos One
|
March 11, 2016
Pharmacological and Genetic Modulation of REV-ERB Activity and Expression Affects Orexigenic Gene Expression
Ariadna Amador, Yongjun Wang, Subhashis Banerjee, et al.
Arthritis Research & Therapy
|
December 8, 2018
Improved patient-reported outcomes in patients with psoriatic arthritis treated with abatacept: results from a phase 3 trial
Vibeke Strand, Evo Alemao, Thomas Lehman, et al.
Page
of 12